Led efforts to advance in vivo cell therapy, next-gen T cell engager, and multi-specific immunotherapy, leveraging our proprietary agentic AI platform for groundbreaking novel target discovery, drug design, biomarker, digital twin and clinical development
Led efforts to advance in vivo cell therapy, next-gen T cell engager, and multi-specific immunotherapy, leveraging our proprietary agentic AI platform for groundbreaking novel target discovery, drug design, biomarker, digital twin and clinical development.